{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:31:43Z","timestamp":1793374303416,"version":"4.5.0"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:00:00Z","timestamp":1626220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:00:00Z","timestamp":1626220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s11427-021-1952-5","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T16:03:01Z","timestamp":1635350581000},"page":"1842-1857","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Recent advances in lentiviral vectors for gene therapy"],"prefix":"10.1007","volume":"64","author":[{"given":"Xiaoyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuicui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Rodr\u00edguez Labrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuquan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,14]]},"reference":[{"key":"1952_CR1","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1007\/s12325-017-0636-2","volume":"34","author":"DE Arnold","year":"2017","unstructured":"Arnold, D.E., and Heimall, J.R. (2017). A review of chronic granulomatous disease. Adv Ther, 34, 2543\u20132557.","journal-title":"Adv Ther"},{"key":"1952_CR2","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio, A., and Schwarzschild, M.A. (2016). The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol, 15, 1257\u20131272.","journal-title":"Lancet Neurol"},{"key":"1952_CR3","doi-asserted-by":"publisher","first-page":"e0212198.","DOI":"10.1371\/journal.pone.0212198","volume":"14","author":"H Baba\u010di\u0107","year":"2019","unstructured":"Baba\u010di\u0107, H., Mehta, A., Merkel, O., and Schoser, B. (2019). CRISPR-Cas gene-editing as plausible treatment of neuromuscular and nucleotiderepeat-expansion diseases: A systematic review. PLoS ONE, 14, e0212198.","journal-title":"PLoS ONE"},{"key":"1952_CR4","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","volume":"377","author":"C Ballard","year":"2011","unstructured":"Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., and Jones, E. (2011). Alzheimer\u2019s disease. Lancet, 377, 1019\u20131031.","journal-title":"Lancet"},{"key":"1952_CR5","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/gt.2011.65","volume":"18","author":"I Barde","year":"2011","unstructured":"Barde, I., Laurenti, E., Verp, S., Wiznerowicz, M., Offner, S., Viornery, A., Galy, A., Trumpp, A., and Trono, D. (2011). Lineage- and stagerestricted lentiviral vectors for the gene therapy of chronic granulomatous disease. Gene Ther, 18, 1087\u20131097.","journal-title":"Gene Ther"},{"key":"1952_CR6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s10875-020-00750-5","volume":"40","author":"L Blancas-Galicia","year":"2020","unstructured":"Blancas-Galicia, L., Santos-Ch\u00e9vez, E., Deswarte, C., Mignac, Q., Medina-Vera, I., Le\u00f3n-Lara, X., Roynard, M., Scheffler-Mendoza, S.C., Rioja-Valencia, R., Alvirde-Ayala, A., et al. (2020). Genetic, immunological, and clinical features of the first mexican cohort of patients with chronic granulomatous disease. J Clin Immunol, 40, 475\u2013493.","journal-title":"J Clin Immunol"},{"key":"1952_CR7","doi-asserted-by":"publisher","first-page":"128.","DOI":"10.3389\/fnana.2016.00128","volume":"10","author":"B Blits","year":"2017","unstructured":"Blits, B., and Petry, H. (2017). Perspective on the road toward gene therapy for Parkinson\u2019s disease. Front Neuroanat, 10, 128.","journal-title":"Front Neuroanat"},{"key":"1952_CR8","doi-asserted-by":"publisher","first-page":"R15","DOI":"10.1093\/hmg\/ddz170","volume":"28","author":"C Booth","year":"2019","unstructured":"Booth, C., Romano, R., Roncarolo, M.G., and Thrasher, A.J. (2019). Gene therapy for primary immunodeficiency. Hum Mol Genet, 28, R15\u2013R23.","journal-title":"Hum Mol Genet"},{"key":"1952_CR9","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s10875-017-0433-3","volume":"37","author":"KL Bradford","year":"2017","unstructured":"Bradford, K.L., Moretti, F.A., Carbonaro-Sarracino, D.A., Gaspar, H.B., and Kohn, D.B. (2017). Adenosine deaminase (ADA)-deficient severe combined immune deficiency (SCID): Molecular pathogenesis and clinical manifestations. J Clin Immunol, 37, 626\u2013637.","journal-title":"J Clin Immunol"},{"key":"1952_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1089\/humc.2017.245","volume":"29","author":"C Brendel","year":"2018","unstructured":"Brendel, C., Rothe, M., Santilli, G., Charrier, S., Stein, S., Kunkel, H., Abriss, D., M\u00fcller-Kuller, U., Gaspar, B., Modlich, U., et al. (2018). Non-clinical efficacy and safety studies on G1XCGD, a lentiviral vector for ex vivo gene therapy of X-linked chronic granulomatous disease. Hum Gene Ther Clin Dev, 29, 69\u201379.","journal-title":"Hum Gene Ther Clin Dev"},{"key":"1952_CR11","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/nbt1372","volume":"25","author":"BD Brown","year":"2007","unstructured":"Brown, B.D., Gentner, B., Cantore, A., Colleoni, S., Amendola, M., Zingale, A., Baccarini, A., Lazzari, G., Galli, C., and Naldini, L. (2007). Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat Biotechnol, 25, 1457\u20131467.","journal-title":"Nat Biotechnol"},{"key":"1952_CR12","doi-asserted-by":"publisher","first-page":"964.","DOI":"10.3389\/fimmu.2020.00964","volume":"11","author":"Y Cai","year":"2020","unstructured":"Cai, Y., and Shi, Q. (2020). Platelet-targeted FVIII gene therapy restores hemostasis and induces immune tolerance for hemophilia A. Front Immunol, 11, 964.","journal-title":"Front Immunol"},{"key":"1952_CR13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.omtm.2017.05.001","volume":"5","author":"K Cambon","year":"2017","unstructured":"Cambon, K., Zimmer, V., Martineau, S., Gaillard, M.C., Jarrige, M., Bugi, A., Miniarikova, J., Rey, M., Hassig, R., Dufour, N., et al. (2017). Preclinical evaluation of a lentiviral vector for Huntingtin silencing. Mol Ther Methods Clin Dev, 5, 259\u2013276.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"1952_CR14","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/mt.2013.265","volume":"22","author":"DA Carbonaro","year":"2014","unstructured":"Carbonaro, D.A., Zhang, L., Jin, X., Montiel-Equihua, C., Geiger, S., Carmo, M., Cooper, A., Fairbanks, L., Kaufman, M.L., Sebire, N.J., et al. (2014). Preclinical demonstration of lentiviral vector-mediated correction of immunological and metabolic abnormalities in models of adenosine deaminase deficiency. Mol Ther, 22, 607\u2013622.","journal-title":"Mol Ther"},{"key":"1952_CR15","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nature09328","volume":"467","author":"M Cavazzana-Calvo","year":"2010","unstructured":"Cavazzana-Calvo, M., Payen, E., Negre, O., Wang, G., Hehir, K., Fusil, F., Down, J., Denaro, M., Brady, T., Westerman, K., et al. (2010). Transfusion independence and HMGA2 activation after gene therapy of human \u03b2-thalassaemia. Nature, 467, 318\u2013322.","journal-title":"Nature"},{"key":"1952_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/cns.12841","volume":"24","author":"C Cepeda","year":"2018","unstructured":"Cepeda, C., and Tong, X.P. (2018). Huntington\u2019s disease: From basic science to therapeutics. CNS Neurosci Ther, 24, 247\u2013249.","journal-title":"CNS Neurosci Ther"},{"key":"1952_CR17","doi-asserted-by":"publisher","first-page":"5460.","DOI":"10.1038\/s41598-018-23795-4","volume":"8","author":"C Chen","year":"2018","unstructured":"Chen, C., Li, X., Ge, G., Liu, J., Biju, K.C., Laing, S.D., Qian, Y., Ballard, C., He, Z., Masliah, E., et al. (2018a). GDNF-expressing macrophages mitigate loss of dopamine neurons and improve Parkinsonian symptoms in MitoPark mice. Sci Rep, 8, 5460.","journal-title":"Sci Rep"},{"key":"1952_CR18","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.gene.2016.04.032","volume":"587","author":"P Chen","year":"2016","unstructured":"Chen, P., Yan, Q., Wang, S., Wang, C., and Zhao, P. (2016). Transfer of three transcription factors via a lentiviral vector ameliorates spatial learning and memory impairment in a mouse model of Alzheimer\u2019s disease. Gene, 587, 59\u201363.","journal-title":"Gene"},{"key":"1952_CR19","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1111\/jth.13800","volume":"15","author":"Y Chen","year":"2017","unstructured":"Chen, Y., Luo, X., Schroeder, J.A., Chen, J., Baumgartner, C.K., Hu, J., and Shi, Q. (2017). Immune tolerance induced by platelet-targeted factor VIII gene therapy in hemophilia A mice is CD4 T cell mediated. J Thromb Haemost, 15, 1994\u20132004.","journal-title":"J Thromb Haemost"},{"key":"1952_CR20","doi-asserted-by":"publisher","first-page":"e58.","DOI":"10.1002\/cpmo.58","volume":"8","author":"YH Chen","year":"2018","unstructured":"Chen, Y.H., Keiser, M.S., and Davidson, B.L. (2018b). Viral vectors for gene transfer. Curr Protoc Mouse Biol, 8, e58.","journal-title":"Curr Protoc Mouse Biol"},{"key":"1952_CR21","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1182\/blood.2020005590","volume":"136","author":"R Chiesa","year":"2020","unstructured":"Chiesa, R., Wang, J., Blok, H.J., Hazelaar, S., Neven, B., Moshous, D., Schulz, A., Hoenig, M., Hauck, F., Al Seraihy, A., et al. (2020). Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults. Blood, 136, 1201\u20131211.","journal-title":"Blood"},{"key":"1952_CR22","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/mt.2014.87","volume":"22","author":"M Chiriaco","year":"2014","unstructured":"Chiriaco, M., Farinelli, G., Capo, V., Zonari, E., Scaramuzza, S., Di Matteo, G., Sergi, L.S., Migliavacca, M., Hernandez, R.J., Bombelli, F., et al. (2014). Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosis. Mol Ther, 22, 1472\u20131483.","journal-title":"Mol Ther"},{"key":"1952_CR23","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/pai.12527","volume":"27","author":"M Chiriaco","year":"2016","unstructured":"Chiriaco, M., Salfa, I., Di Matteo, G., Rossi, P., and Finocchi, A. (2016). Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects. Pediatr Allergy Immunol, 27, 242\u2013253.","journal-title":"Pediatr Allergy Immunol"},{"key":"1952_CR24","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/nyas.12849","volume":"1356","author":"E Cirillo","year":"2015","unstructured":"Cirillo, E., Giardino, G., Gallo, V., D'Assante, R., Grasso, F., Romano, R., Di Lillo, C., Galasso, G., and Pignata, C. (2015). Severe combined immunodeficiency-an update. Ann NY Acad Sci, 1356, 90\u2013106.","journal-title":"Ann NY Acad Sci"},{"key":"1952_CR25","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41431-018-0309-x","volume":"27","author":"MC Cornel","year":"2019","unstructured":"Cornel, M.C., Howard, H.C., Lim, D., Bonham, V.L., and Wartiovaara, K. (2019). Moving towards a cure in genetics: what is needed to bring somatic gene therapy to the clinic? Eur J Hum Genet, 27, 484\u2013487.","journal-title":"Eur J Hum Genet"},{"key":"1952_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/B978-0-12-800548-4.00011-5","volume-title":"Translating Regenerative Medicine to the Clinic","author":"A Crespo-Barreda","year":"2016","unstructured":"Crespo-Barreda, A., Encabo-Berzosa, M.M., Gonz\u00e9lez-Pastor, R., Ort\u00edz-Teba, P., Iglesias, M., Serrano, J.L., and Martin-Duque, P. (2016). Chapter 11-Viral and nonviral vectors for in vivo and ex vivo gene therapies. In: Laurence, J., ed. Translating Regenerative Medicine to the Clinic. Boston: Academic Press. 155\u2013177."},{"key":"1952_CR27","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","volume":"127","author":"L Cui","year":"2006","unstructured":"Cui, L., Jeong, H., Borovecki, F., Parkhurst, C.N., Tanese, N., and Krainc, D. (2006). Transcriptional repression of PGC-1\u03b1 by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell, 127, 59\u201369.","journal-title":"Cell"},{"key":"1952_CR28","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1093\/hmg\/ddt242","volume":"22","author":"M Damiano","year":"2013","unstructured":"Damiano, M., Diguet, E., Malgorn, C., D\u2019Aurelio, M., Galvan, L., Petit, F., Benhaim, L., Guillermier, M., Houitte, D., Dufour, N., et al. (2013). A role of mitochondrial complex II defects in genetic models of Huntington\u2019s disease expressing N-terminal fragments of mutant huntingtin. Hum Mol Genet, 22, 3869\u20133882.","journal-title":"Hum Mol Genet"},{"key":"1952_CR29","doi-asserted-by":"publisher","first-page":"335ra57.","DOI":"10.1126\/scitranslmed.aad8856","volume":"8","author":"SS De Ravin","year":"2016","unstructured":"De Ravin, S.S., Wu, X., Moir, S., Anaya-O'Brien, S., Kwatemaa, N., Littel, P., Theobald, N., Choi, U., Su, L., Marquesen, M., et al. (2016). Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency. Sci Transl Med, 8, 335ra57.","journal-title":"Sci Transl Med"},{"key":"1952_CR30","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.jcyt.2018.04.003","volume":"20","author":"S Demirci","year":"2018","unstructured":"Demirci, S., Uchida, N., and Tisdale, J.F. (2018). Gene therapy for sickle cell disease: An update. Cytotherapy, 20, 899\u2013910.","journal-title":"Cytotherapy"},{"key":"1952_CR31","doi-asserted-by":"publisher","first-page":"702.","DOI":"10.4103\/1673-5374.187027","volume":"11","author":"P Deng","year":"2016","unstructured":"Deng, P., Torrest, A., Pollock, K., Dahlenburg, H., Annett, G., Nolta, J.A., and Fink, K.D. (2016). Clinical trial perspective for adult and juvenile Huntington\u2019s disease using genetically-engineered mesenchymal stem cells. Neural Regen Res, 11, 702.","journal-title":"Neural Regen Res"},{"key":"1952_CR32","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s11427-016-0017-3","volume":"59","author":"G Ding","year":"2016","unstructured":"Ding, G., and Chen, H. (2016). Adoptive transfer of T cells transduced with a chimeric antigen receptor to treat relapsed or refractory acute leukemia: efficacy and feasibility of immunotherapy approaches. Sci China Life Sci, 59, 673\u2013677.","journal-title":"Sci China Life Sci"},{"key":"1952_CR33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1182\/blood-2017-07-791608","volume":"131","author":"RG Dossa","year":"2018","unstructured":"Dossa, R.G., Cunningham, T., Sommermeyer, D., Medina-Rodriguez, I., Biernacki, M.A., Foster, K., and Bleakley, M. (2018). Development of T-cell immunotherapy for hematopoietic stem cell transplantation recipients at risk of leukemia relapse. Blood, 131, 108\u2013120.","journal-title":"Blood"},{"key":"1952_CR34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s12033-010-9334-x","volume":"47","author":"JL Dreyer","year":"2011","unstructured":"Dreyer, J.L. (2011). Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions. Mol Biotechnol, 47, 169\u2013187.","journal-title":"Mol Biotechnol"},{"key":"1952_CR35","doi-asserted-by":"publisher","first-page":"15156.","DOI":"10.1038\/s41598-018-33509-5","volume":"8","author":"Y Egashira","year":"2018","unstructured":"Egashira, Y., Mori, Y., Yanagawa, Y., and Takamori, S. (2018). Development of lentiviral vectors for efficient glutamatergic-selective gene expression in cultured hippocampal neurons. Sci Rep, 8, 15156.","journal-title":"Sci Rep"},{"key":"1952_CR36","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.omtm.2020.03.001","volume":"17","author":"N El-Akabawy","year":"2020","unstructured":"El-Akabawy, N., Rodriguez, M., Ramamurthy, R., Rabah, A., Trevisan, B., Morsi, A., George, S., Shields, J., Meares, D., Farland, A., et al. (2020). Defining the optimal FVIII transgene for placental cell-based gene therapy to treat hemophilia A. Mol Ther Methods Clin Dev, 17, 465\u2013477.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"1952_CR37","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1038\/mt.2013.132","volume":"21","author":"SM Ellison","year":"2013","unstructured":"Ellison, S.M., Trabalza, A., Tisato, V., Pazarentzos, E., Lee, S., Papadaki, V., Goniotaki, D., Morgan, S., Mirzaei, N., and Mazarakis, N.D. (2013). Dose-dependent neuroprotection of VEGF165 in Huntington\u2019s disease striatum. Mol Ther, 21, 1862\u20131875.","journal-title":"Mol Ther"},{"key":"1952_CR38","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/WCO.0000000000000835","volume":"33","author":"C Estevez-Fraga","year":"2020","unstructured":"Estevez-Fraga, C., Flower, M.D., and Tabrizi, S.J. (2020). Therapeutic strategies for Huntington\u2019s disease. Curr Opin Neurol, 33, 508\u2013518.","journal-title":"Curr Opin Neurol"},{"key":"1952_CR39","first-page":"5","volume":"46","author":"E Fanales-Belasio","year":"2010","unstructured":"Fanales-Belasio, E., Raimondo, M., Suligoi, B., and Butt\u00f2, S. (2010). HIV virology and pathogenetic mechanisms of infection: a brief overview. Ann Ist Super Sanita, 46, 5\u201314.","journal-title":"Ann Ist Super Sanita"},{"key":"1952_CR40","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1038\/mt.2016.150","volume":"24","author":"G Farinelli","year":"2016","unstructured":"Farinelli, G., Jofra Hernandez, R., Rossi, A., Ranucci, S., Sanvito, F., Migliavacca, M., Brombin, C., Pramov, A., Di Serio, C., Bovolenta, C., et al. (2016). Lentiviral vector gene therapy protects XCGD mice from acute Staphylococcus aureus pneumonia and inflammatory response. Mol Ther, 24, 1873\u20131880.","journal-title":"Mol Ther"},{"key":"1952_CR41","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41576-020-00298-5","volume":"22","author":"G Ferrari","year":"2021","unstructured":"Ferrari, G., Thrasher, A.J., and Aiuti, A. (2021). Gene therapy using haematopoietic stem and progenitor cells. Nat Rev Genet, 22, 216\u2013234.","journal-title":"Nat Rev Genet"},{"key":"1952_CR42","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1089\/hum.2017.175","volume":"28","author":"F Ferrua","year":"2017","unstructured":"Ferrua, F., and Aiuti, A. (2017). Twenty-five years of gene therapy for ADA-SCID: From bubble babies to an approved drug. Hum Gene Ther, 28, 972\u2013981.","journal-title":"Hum Gene Ther"},{"key":"1952_CR43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13023-018-0807-5","volume":"13","author":"AM Flinn","year":"2018","unstructured":"Flinn, A.M., and Gennery, A.R. (2018). Adenosine deaminase deficiency: a review. Orphanet J Rare Dis 13, 65.","journal-title":"Orphanet J Rare Dis"},{"key":"1952_CR44","doi-asserted-by":"publisher","first-page":"3505.","DOI":"10.1038\/s41467-020-17256-8","volume":"11","author":"AC Francis","year":"2020","unstructured":"Francis, A.C., Marin, M., Singh, P.K., Achuthan, V., Prellberg, M.J., Palermino-Rowland, K., Lan, S., Tedbury, P.R., Sarafianos, S.G., Engelman, A.N., et al. (2020). HIV-1 replication complexes accumulate in nuclear speckles and integrate into speckle-associated genomic domains. Nat Commun, 11, 3505.","journal-title":"Nat Commun"},{"key":"1952_CR45","first-page":"108","volume":"107","author":"LB Gao","year":"2016","unstructured":"Gao, L.B., Yu, X. F., Chen, Q., and Zhou, D. (2016). Alzheimer\u2019s disease therapeutics: current and future therapies. Minerva Med, 107, 108\u2013113.","journal-title":"Minerva Med"},{"key":"1952_CR46","doi-asserted-by":"publisher","first-page":"549.","DOI":"10.3390\/pharmaceutics12060549","volume":"12","author":"L Garcia-Perez","year":"2020","unstructured":"Garcia-Perez, L., Ordas, A., Cant\u00e9-Barrett, K., Meij, P., Pike-Overzet, K., Lankester, A., and Staal, F.J.T. (2020). Preclinical development of autologous hematopoietic stem cell-based gene therapy for immune deficiencies: a journey from mouse cage to bed side. Pharmaceutics, 12, 549.","journal-title":"Pharmaceutics"},{"key":"1952_CR47","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1089\/scd.2018.0030","volume":"27","author":"G Ge","year":"2018","unstructured":"Ge, G., Chen, C., Guderyon, M.J., Liu, J., He, Z., Yu, Y., Clark, R.A., and Li, S. (2018). Regulatable lentiviral hematopoietic stem cell gene therapy in a mouse model of Parkinson\u2019s disease. Stem Cells Dev, 27, 995\u20131005.","journal-title":"Stem Cells Dev"},{"key":"1952_CR48","doi-asserted-by":"publisher","first-page":"1016.","DOI":"10.3390\/v12091016","volume":"12","author":"A Gutierrez-Guerrero","year":"2020","unstructured":"Gutierrez-Guerrero, A., Cosset, F.L., and Verhoeyen, E. (2020). Lentiviral vector pseudotypes: precious tools to improve gene modification of hematopoietic cells for research and gene therapy. Viruses, 12, 1016.","journal-title":"Viruses"},{"key":"1952_CR49","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/S0140-6736(18)30422-7","volume":"391","author":"M Hallek","year":"2018","unstructured":"Hallek, M., Shanafelt, T.D., and Eichhorst, B. (2018). Chronic lymphocytic leukaemia. Lancet, 391, 1524\u20131537.","journal-title":"Lancet"},{"key":"1952_CR50","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMra1706910","volume":"381","author":"KA High","year":"2019","unstructured":"High, K.A., and Roncarolo, M.G. (2019). Gene therapy. N Engl J Med 381, 455\u2013464.","journal-title":"N Engl J Med"},{"key":"1952_CR51","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/sj.gt.3302924","volume":"14","author":"H Hioki","year":"2007","unstructured":"Hioki, H., Kameda, H., Nakamura, H., Okunomiya, T., Ohira, K., Nakamura, K., Kuroda, M., Furuta, T., and Kaneko, T. (2007). Efficient gene transduction of neurons by lentivirus with enhanced neuron-specific promoters. Gene Ther, 14, 872\u2013882.","journal-title":"Gene Ther"},{"key":"1952_CR52","doi-asserted-by":"publisher","first-page":"S1.","DOI":"10.1038\/d41586-018-05717-6","volume":"559","author":"R Hodson","year":"2018","unstructured":"Hodson, R. (2018). Alzheimer\u2019s disease. Nature, 559, S1.","journal-title":"Nature"},{"key":"1952_CR53","doi-asserted-by":"publisher","first-page":"e2717.","DOI":"10.1038\/cddis.2017.140","volume":"8","author":"R Hu","year":"2017","unstructured":"Hu, R., Wei, P., Jin, L., Zheng, T., Chen, W.Y., Liu, X.Y., Shi, X.D., Hao, J. R., Sun, N., and Gao, C. (2017). Overexpression of EphB2 in hippocampus rescues impaired NMDA receptors trafficking and cognitive dysfunction in Alzheimer model. Cell Death Dis, 8, e2717.","journal-title":"Cell Death Dis"},{"key":"1952_CR54","doi-asserted-by":"publisher","first-page":"R24","DOI":"10.1093\/hmg\/ddz172","volume":"28","author":"Y Ikawa","year":"2019","unstructured":"Ikawa, Y., Miccio, A., Magrin, E., Kwiatkowski, J.L., Rivella, S., and Cavazzana, M. (2019). Gene therapy of hemoglobinopathies: progress and future challenges. Hum Mol Genet, 28, R24\u2013R30.","journal-title":"Hum Mol Genet"},{"key":"1952_CR55","first-page":"131","volume":"18","author":"A Jafarian","year":"2019","unstructured":"Jafarian, A., Shokri, G., Shokrollahi Barough, M., Moin, M., Pourpak, Z., and Soleimani, M. (2019). Recent advances in gene therapy and modeling of chronic granulomatous disease. Iran J Allergy Asthma Immunol, 18, 131\u2013142.","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"1952_CR56","doi-asserted-by":"publisher","first-page":"a024240.","DOI":"10.1101\/cshperspect.a024240","volume":"7","author":"M Jimenez-Sanchez","year":"2017","unstructured":"Jimenez-Sanchez, M., Licitra, F., Underwood, B.R., and Rubinsztein, D.C. (2017). Huntington\u2019s disease: mechanisms of pathogenesis and therapeutic strategies. Cold Spring Harb Perspect Med, 7, a024240.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1952_CR57","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1182\/bloodadvances.2019000650","volume":"3","author":"W Jing","year":"2019","unstructured":"Jing, W., Chen, J., Cai, Y., Chen, Y., Schroeder, J.A., Johnson, B.D., Cui, W., and Shi, Q. (2019). Induction of activated T follicular helper cells is critical for anti-FVIII inhibitor development in hemophilia A mice. Blood Adv, 3, 3099\u20133110.","journal-title":"Blood Adv"},{"key":"1952_CR58","volume-title":"Science","author":"J Kaiser","year":"2021","unstructured":"Kaiser, J. (2021). Gene therapy trials for sickle cell disease halted after two patients develop cancer. Science doi: 10.1126\/science.abh1106."},{"key":"1952_CR59","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3233\/JAD-2011-101356","volume":"25","author":"L Katsouri","year":"2011","unstructured":"Katsouri, L., Parr, C., Bogdanovic, N., Willem, M., and Sastre, M. (2011). PPAR\u03b3-coactivator-1\u03b1 (PGC-1\u03b1) reduces amyloid-\u03b2 generation through a PPAR\u03b3-dependent mechanism. J Alzheimers Dis, 25, 151\u2013162.","journal-title":"J Alzheimers Dis"},{"key":"1952_CR60","doi-asserted-by":"publisher","first-page":"12292","DOI":"10.1073\/pnas.1606171113","volume":"113","author":"L Katsouri","year":"2016","unstructured":"Katsouri, L., Lim, Y.M., Blondrath, K., Eleftheriadou, I., Lombardero, L., Birch, A.M., Mirzaei, N., Irvine, E.E., Mazarakis, N.D., and Sastre, M. (2016). PPAR?-coactivator-1\u03b1 gene transfer reduces neuronal loss and amyloid-\u03b2 generation by reducing \u03b2-secretase in an Alzheimer\u2019s disease model. Proc Natl Acad Sci USA, 113, 12292\u201312297.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1952_CR61","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1128\/JVI.72.1.811-816.1998","volume":"72","author":"VN Kim","year":"1998","unstructured":"Kim, V.N., Mitrophanous, K., Kingsman, S.M., and Kingsman, A.J. (1998). Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1. J Virol, 72, 811\u2013816.","journal-title":"J Virol"},{"key":"1952_CR62","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41591-019-0735-5","volume":"26","author":"DB Kohn","year":"2020","unstructured":"Kohn, D.B., Booth, C., Kang, E.M., Pai, S.Y., Shaw, K.L., Santilli, G., Armant, M., Buckland, K.F., Choi, U., De Ravin, S.S., et al. (2020). Lentiviral gene therapy for X-linked chronic granulomatous disease. Nat Med, 26, 200\u2013206.","journal-title":"Nat Med"},{"key":"1952_CR63","doi-asserted-by":"publisher","first-page":"754.","DOI":"10.3390\/ijms18040754","volume":"18","author":"N Kolli","year":"2017","unstructured":"Kolli, N., Lu, M., Maiti, P., Rossignol, J., and Dunbar, G.L. (2017). CRISPR-Cas9 mediated gene-silencing of the mutant Huntingtin gene in an in vitro model of Huntington\u2019s disease. Int J Mol Sci, 18, 754.","journal-title":"Int J Mol Sci"},{"key":"1952_CR64","doi-asserted-by":"publisher","first-page":"5032","DOI":"10.1016\/j.jmb.2019.09.021","volume":"431","author":"W Kong","year":"2019","unstructured":"Kong, W., Rivera-Serrano, E.E., Neidleman, J.A., and Zhu, J. (2019). HIV-1 replication benefits from the RNA epitranscriptomic code. J Mol Biol, 431, 5032\u20135038.","journal-title":"J Mol Biol"},{"key":"1952_CR65","doi-asserted-by":"publisher","first-page":"27518","DOI":"10.1074\/jbc.M402578200","volume":"279","author":"DN Levasseur","year":"2004","unstructured":"Levasseur, D.N., Ryan, T.M., Reilly, M.P., McCune, S.L., Asakura, T., and Townes, T.M. (2004). A recombinant human hemoglobin with antisickling properties greater than fetal hemoglobin. J Biol Chem, 279, 27518\u201327524.","journal-title":"J Biol Chem"},{"key":"1952_CR66","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.arr.2018.03.004","volume":"44","author":"J Lv","year":"2018","unstructured":"Lv, J., Jiang, S., Yang, Z., Hu, W., Wang, Z., Li, T., and Yang, Y. (2018). PGC-1\u03b1 sparks the fire of neuroprotection against neurodegenerative disorders. Ageing Res Rev, 44, 8\u201321.","journal-title":"Ageing Res Rev"},{"key":"1952_CR67","doi-asserted-by":"publisher","first-page":"107502.","DOI":"10.1016\/j.biotechadv.2019.107502","volume":"40","author":"CC Ma","year":"2020","unstructured":"Ma, C.C., Wang, Z.L., Xu, T., He, Z.Y., and Wei, Y.Q. (2020). The approved gene therapy drugs worldwide: from 1998 to 2019. Biotech Adv, 40, 107502.","journal-title":"Biotech Adv"},{"key":"1952_CR68","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1182\/blood.2019000949","volume":"134","author":"E Magrin","year":"2019","unstructured":"Magrin, E., Miccio, A., and Cavazzana, M. (2019). Lentiviral and genomeediting strategies for the treatment of \u03b2-hemoglobinopathies. Blood, 134, 1203\u20131213.","journal-title":"Blood"},{"key":"1952_CR69","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1056\/NEJMoa1815408","volume":"380","author":"E Mamcarz","year":"2019","unstructured":"Mamcarz, E., Zhou, S., Lockey, T., Abdelsamed, H., Cross, S.J., Kang, G., Ma, Z., Condori, J., Dowdy, J., Triplett, B., et al. (2019). Lentiviral gene therapy combined with low-dose busulfan in infants with SCID-X1. N Engl J Med, 380, 1525\u20131534.","journal-title":"N Engl J Med"},{"key":"1952_CR70","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3324\/haematol.2019.232132","volume":"105","author":"PM Mannucci","year":"2020","unstructured":"Mannucci, P.M. (2020). Hemophilia therapy: the future has begun. Haematologica, 105, 545\u2013553.","journal-title":"Haematologica"},{"key":"1952_CR71","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41591-018-0301-6","volume":"25","author":"S Marktel","year":"2019","unstructured":"Marktel, S., Scaramuzza, S., Cicalese, M.P., Giglio, F., Galimberti, S., Lidonnici, M.R., Calbi, V., Assanelli, A., Bernardo, M.E., Rossi, C., et al. (2019). Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent \u03b2-thalassemia. Nat Med, 25, 234\u2013241.","journal-title":"Nat Med"},{"key":"1952_CR72","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1093\/hmg\/ddr148","volume":"20","author":"E Martin","year":"2011","unstructured":"Martin, E., Betuing, S., Pag\u00e8s, C., Cambon, K., Auregan, G., Deglon, N., Roze, E., and Caboche, J. (2011). Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington\u2019s disease: role on chromatin remodeling at the PGC-1-alpha promoter. Hum Mol Genet, 20, 2422\u20132434.","journal-title":"Hum Mol Genet"},{"key":"1952_CR73","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","volume":"371","author":"SL Maude","year":"2014","unstructured":"Maude, S.L., Frey, N., Shaw, P.A., Aplenc, R., Barrett, D.M., Bunin, N.J., Chew, A., Gonzalez, V.E., Zheng, Z., Lacey, S.F., et al. (2014). Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med, 371, 1507\u20131517.","journal-title":"N Engl J Med"},{"key":"1952_CR74","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1016\/j.celrep.2017.08.075","volume":"20","author":"N Merienne","year":"2017","unstructured":"Merienne, N., Vachey, G., de Longprez, L., Meunier, C., Zimmer, V., Perriard, G., Canales, M., Mathias, A., Herrgott, L., Beltraminelli, T., et al. (2017). The self-inactivating KamiCas9 system for the editing of CNS disease genes. Cell Rep, 20, 2980\u20132991.","journal-title":"Cell Rep"},{"key":"1952_CR75","doi-asserted-by":"publisher","first-page":"10547","DOI":"10.1073\/pnas.0711666105","volume":"105","author":"A Miccio","year":"2008","unstructured":"Miccio, A., Cesari, R., Lotti, F., Rossi, C., Sanvito, F., Ponzoni, M., Routledge, S.J.E., Chow, C.M., Antoniou, M.N., and Ferrari, G. (2008). In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of \u03b2-thalassemia. Proc Natl Acad Sci USA, 105, 10547\u201310552.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1952_CR76","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1038\/mt.2009.83","volume":"17","author":"MC Milone","year":"2009","unstructured":"Milone, M.C., Fish, J.D., Carpenito, C., Carroll, R.G., Binder, G.K., Teachey, D., Samanta, M., Lakhal, M., Gloss, B., Danet-Desnoyers, G., et al. (2009). Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo. Mol Ther, 17, 1453\u20131464.","journal-title":"Mol Ther"},{"key":"1952_CR77","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","volume":"32","author":"MC Milone","year":"2018","unstructured":"Milone, M.C., and O\u2019Doherty, U. (2018). Clinical use of lentiviral vectors. Leukemia, 32, 1529\u20131541.","journal-title":"Leukemia"},{"key":"1952_CR78","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.ymthe.2019.09.020","volume":"28","author":"RA Morgan","year":"2020","unstructured":"Morgan, R.A., Unti, M.J., Aleshe, B., Brown, D., Osborne, K.S., Koziol, C., Ayoub, P.G., Smith, O.B., O'Brien, R., Tam, C., et al. (2020). Improved titer and gene transfer by lentiviral vectors using novel, small \u03b2-globin locus control region elements. Mol Ther, 28, 328\u2013340.","journal-title":"Mol Ther"},{"key":"1952_CR79","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1182\/blood-2006-05-023507","volume":"108","author":"A Mortellaro","year":"2006","unstructured":"Mortellaro, A., Hernandez, R.J., Guerrini, M.M., Carlucci, F., Tabucchi, A., Ponzoni, M., Sanvito, F., Doglioni, C., Di Serio, C., Biasco, L., et al. (2006). Ex vivo gene therapy with lentiviral vectors rescues adenosine deaminase (ADA)-deficient mice and corrects their immune and metabolic defects. Blood, 108, 2979\u20132988.","journal-title":"Blood"},{"key":"1952_CR80","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/s41431-020-0607-y","volume":"28","author":"M Mourby","year":"2020","unstructured":"Mourby, M., and Morrison, M. (2020). Gene therapy regulation: could inbody editing fall through the net? Eur J Hum Genet, 28, 979\u2013981.","journal-title":"Eur J Hum Genet"},{"key":"1952_CR81","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2174\/1566523214666141127095336","volume":"15","author":"O Negre","year":"2015","unstructured":"Negre, O., Bartholomae, C., Beuzard, Y., Cavazzana, M., Christiansen, L., Courne, C., Deichmann, A., Denaro, M., de Dreuzy, E., Finer, M., et al. (2015). Preclinical evaluation of efficacy and safety of an improved lentiviral vector for the treatment of \u03b2-thalassemia and sickle cell disease. Curr Gene Ther, 15, 64\u201381.","journal-title":"Curr Gene Ther"},{"key":"1952_CR82","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1089\/hum.2016.007","volume":"27","author":"O Negre","year":"2016","unstructured":"Negre, O., Eggimann, A.V., Beuzard, Y., Ribeil, J.A., Bourget, P., Borwornpinyo, S., Hongeng, S., Hacein-Bey, S., Cavazzana, M., Leboulch, P., et al. (2016). Gene therapy of the \u03b2-hemoglobinopathies by lentiviral transfer of the \u03b2A(T87Q)-Globin gene. Hum Gene Ther, 27, 148\u2013165.","journal-title":"Hum Gene Ther"},{"key":"1952_CR83","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12185-018-2513-4","volume":"111","author":"T Ohmori","year":"2020","unstructured":"Ohmori, T. (2020). Advances in gene therapy for hemophilia: basis, current status, and future perspectives. Int J Hematol, 111, 31\u201341.","journal-title":"Int J Hematol"},{"key":"1952_CR84","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s11262-017-1495-2","volume":"53","author":"H Olbrich","year":"2017","unstructured":"Olbrich, H., Slabik, C., and Stripecke, R. (2017). Reconstructing the immune system with lentiviral vectors. Virus Genes, 53, 723\u2013732.","journal-title":"Virus Genes"},{"key":"1952_CR85","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.stemcr.2018.10.012","volume":"11","author":"C Olgasi","year":"2018","unstructured":"Olgasi, C., Talmon, M., Merlin, S., Cucci, A., Richaud-Patin, Y., Ranaldo, G., Colangelo, D., Di Scipio, F., Berta, G.N., Borsotti, C., et al. (2018). Patient-specific iPSC-derived endothelial cells provide long-term phenotypic correction of hemophilia A. Stem Cell Rep, 11, 1391\u20131406.","journal-title":"Stem Cell Rep"},{"key":"1952_CR86","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/gim.2016.173","volume":"19","author":"R Origa","year":"2017","unstructured":"Origa, R. (2017). \u03b2-Thalassemia. Genet Med, 19, 609\u2013619.","journal-title":"Genet Med"},{"key":"1952_CR87","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/S0140-6736(13)61939-X","volume":"383","author":"S Palfi","year":"2014","unstructured":"Palfi, S., Gurruchaga, J.M., Ralph, G.S., Lepetit, H., Lavisse, S., Buttery, P. C., Watts, C., Miskin, J., Kelleher, M., Deeley, S., et al. (2014). Longterm safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson\u2019s disease: a dose escalation, open-label, phase 1\/2 trial. Lancet, 383, 1138\u20131146.","journal-title":"Lancet"},{"key":"1952_CR88","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1089\/humc.2018.081","volume":"29","author":"S Palfi","year":"2018","unstructured":"Palfi, S., Gurruchaga, J.M., Lepetit, H., Howard, K., Ralph, G.S., Mason, S., Gouello, G., Domenech, P., Buttery, P.C., Hantraye, P., et al. (2018). Long-term follow-up of a phase I\/II study of ProSavin, a lentiviral vector gene therapy for Parkinson\u2019s disease. Hum Gene Ther Clin Dev, 29, 148\u2013155.","journal-title":"Hum Gene Ther Clin Dev"},{"key":"1952_CR89","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/S1525-0016(03)00169-2","volume":"8","author":"F Park","year":"2003","unstructured":"Park, F., Ohashi, K., and Kay, M.A. (2003). The effect of age on hepatic gene transfer with self-inactivating lentiviral vectors in vivo. Mol Ther, 8, 314\u2013323.","journal-title":"Mol Ther"},{"key":"1952_CR90","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrd.2018.70","volume":"17","author":"R Peters","year":"2018","unstructured":"Peters, R., and Harris, T. (2018). Advances and innovations in haemophilia treatment. Nat Rev Drug Discov, 17, 493\u2013508.","journal-title":"Nat Rev Drug Discov"},{"key":"1952_CR91","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJMra1510865","volume":"376","author":"FB Piel","year":"2017","unstructured":"Piel, F.B., Steinberg, M.H., and Rees, D.C. (2017). Sickle cell disease. N Engl J Med, 376, 1561\u20131573.","journal-title":"N Engl J Med"},{"key":"1952_CR92","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.omtm.2018.10.014","volume":"11","author":"V Poletti","year":"2018","unstructured":"Poletti, V., Urbinati, F., Charrier, S., Corre, G., Hollis, R.P., Campo Fernandez, B., Martin, S., Rothe, M., Schambach, A., Kohn, D.B., et al. (2018). Pre-clinical development of a lentiviral vector expressing the anti-sickling \u03b2AS3 globin for gene therapy for sickle cell disease. Mol Ther Methods Clin Dev, 11, 167\u2013179.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"1952_CR93","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/mt.2016.12","volume":"24","author":"K Pollock","year":"2016","unstructured":"Pollock, K., Dahlenburg, H., Nelson, H., Fink, K.D., Cary, W., Hendrix, K., Annett, G., Torrest, A., Deng, P., Gutierrez, J., et al. (2016). Human mesenchymal stem cells genetically engineered to overexpress brainderived neurotrophic factor improve outcomes in Huntington\u2019s disease mouse models. Mol Ther, 24, 965\u2013977.","journal-title":"Mol Ther"},{"key":"1952_CR94","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa1103849","volume":"365","author":"DL Porter","year":"2011","unstructured":"Porter, D.L., Levine, B.L., Kalos, M., Bagg, A., and June, C.H. (2011). Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N Engl J Med, 365, 725\u2013733.","journal-title":"N Engl J Med"},{"key":"1952_CR95","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1001\/archneurol.2008.588","volume":"66","author":"W Qin","year":"2009","unstructured":"Qin, W., Haroutunian, V., Katsel, P., Cardozo, C.P., Ho, L., Buxbaum, J.D., and Pasinetti, G.M. (2009). PGC-1\u03b1 expression decreases in the Alzheimer disease brain as a function of dementia. Arch Neurol, 66, 352\u2013361.","journal-title":"Arch Neurol"},{"key":"1952_CR96","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s12035-018-1068-y","volume":"56","author":"SP Raikwar","year":"2019","unstructured":"Raikwar, S.P., Thangavel, R., Dubova, I., Selvakumar, G.P., Ahmed, M.E., Kempuraj, D., Zaheer, S.A., Iyer, S.S., and Zaheer, A. (2019). Targeted gene editing of glia maturation factor in microglia: a novel Alzheimer\u2019s disease therapeutic target. Mol Neurobiol, 56, 378\u2013393.","journal-title":"Mol Neurobiol"},{"key":"1952_CR97","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1073\/pnas.96.5.2129","volume":"96","author":"JEJ Rasko","year":"1999","unstructured":"Rasko, J.E.J., Battini, J.L., Gottschalk, R.J., Mazo, I., and Dusty Miller, A. (1999). The RD114\/simian type D retrovirus receptor is a neutral amino acid transporter. Proc Natl Acad Sci USA, 96, 2129\u20132134.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1952_CR98","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1056\/NEJMoa1609677","volume":"376","author":"JA Ribeil","year":"2017","unstructured":"Ribeil, J.A., Hacein-Bey-Abina, S., Payen, E., Magnani, A., Semeraro, M., Magrin, E., Caccavelli, L., Neven, B., Bourget, P., El Nemer, W., et al. (2017). Gene therapy in a patient with sickle cell disease. N Engl J Med, 376, 848\u2013855.","journal-title":"N Engl J Med"},{"key":"1952_CR99","doi-asserted-by":"publisher","first-page":"105024.","DOI":"10.1016\/j.nbd.2020.105024","volume":"144","author":"S Rolfes","year":"2020","unstructured":"Rolfes, S., Munro, D.A.D., Lyras, E.M., Matute, E., Ouk, K., Harms, C., B\u00f8ttcher, C., and Priller, J. (2020). Lentiviral delivery of human erythropoietin attenuates hippocampal atrophy and improves cognition in the R6\/2 mouse model of Huntington\u2019s disease. Neurobiol Dis, 144, 105024.","journal-title":"Neurobiol Dis"},{"key":"1952_CR100","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/sctm.19-0261","volume":"9","author":"M Rose","year":"2020","unstructured":"Rose, M., Gao, K., Cortez-Toledo, E., Agu, E., Hyllen, A.A., Conroy, K., Pan, G., Nolta, J.A., Wang, A., and Zhou, P. (2020). Endothelial cells derived from patients\u2019 induced pluripotent stem cells for sustained factor VIII delivery and the treatment of hemophilia A. Stem Cells Transl Med, 9, 686\u2013696.","journal-title":"Stem Cells Transl Med"},{"key":"1952_CR101","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","volume":"363","author":"A Samii","year":"2004","unstructured":"Samii, A., Nutt, J.G., and Ransom, B.R. (2004). Parkinson\u2019s disease. Lancet, 363, 1783\u20131793.","journal-title":"Lancet"},{"key":"1952_CR102","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/mt.2010.226","volume":"19","author":"G Santilli","year":"2011","unstructured":"Santilli, G., Almarza, E., Brendel, C., Choi, U., Beilin, C., Blundell, M.P., Haria, S., Parsley, K.L., Kinnon, C., Malech, H.L., et al. (2011). Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells. Mol Ther, 19, 122\u2013132.","journal-title":"Mol Ther"},{"key":"1952_CR103","first-page":"P.E., and Song,","volume":"26-45.Saw","author":"AO Sasmita","year":"2019","unstructured":"Sasmita, A.O. (2019). Current viral-mediated gene transfer research for treatment of Alzheimer\u2019s disease. Biotech Genet Eng Rev 35, 26-45. Saw, P.E., and Song, E.W. (2020). siRNA therapeutics: a clinical reality. Sci China Life Sci, 63, 485\u2013500.","journal-title":"Biotech Genet Eng Rev 35"},{"key":"1952_CR104","doi-asserted-by":"publisher","first-page":"100588.","DOI":"10.1016\/j.blre.2019.100588","volume":"37","author":"FT Shah","year":"2019","unstructured":"Shah, F.T., Sayani, F., Trompeter, S., Drasar, E., and Piga, A. (2019). Challenges of blood transfusions in \u03b2-thalassemia. Blood Rev, 37, 100588.","journal-title":"Blood Rev"},{"key":"1952_CR105","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1172\/JCI90367","volume":"127","author":"KL Shaw","year":"2017","unstructured":"Shaw, K.L., Garabedian, E., Mishra, S., Barman, P., Davila, A., Carbonaro, D., Shupien, S., Silvin, C., Geiger, S., Nowicki, B., et al. (2017). Clinical efficacy of gene-modified stem cells in adenosine deaminasedeficient immunodeficiency. J Clin Invest, 127, 1689\u20131699.","journal-title":"J Clin Invest"},{"key":"1952_CR106","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1538-7836.2007.02346.x","volume":"5","author":"Q Shi","year":"2007","unstructured":"Shi, Q., Wilcox, D.A., Fahs, S.A., Fang, J., Johnson, B.D., Du, L.M., Desai, D., and Montgomery, R.R. (2007). Lentivirus-mediated platelet-derived factor VIII gene therapy in murine haemophilia A. J Thromb Haemost, 5, 352\u2013361.","journal-title":"J Thromb Haemost"},{"key":"1952_CR107","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/gt.2017.67","volume":"24","author":"JM Staber","year":"2017","unstructured":"Staber, J.M., Pollpeter, M.J., Anderson, C.G., Burrascano, M., Cooney, A. L., Sinn, P.L., Rutkowski, D.T., Raschke, W.C., and McCray, P.B. (2017). Long-term correction of hemophilia A mice following lentiviral mediated delivery of an optimized canine factor VIII gene. Gene Ther, 24, 742\u2013748.","journal-title":"Gene Ther"},{"key":"1952_CR108","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nn1360","volume":"8","author":"E Storkebaum","year":"2005","unstructured":"Storkebaum, E., Lambrechts, D., Dewerchin, M., Moreno-Murciano, M.P., Appelmans, S., Oh, H., Van Damme, P., Rutten, B., Man, W.Y., De Mol, M., et al. (2005). Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci, 8, 85\u201392.","journal-title":"Nat Neurosci"},{"key":"1952_CR109","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.neuron.2019.01.039","volume":"101","author":"SJ Tabrizi","year":"2019","unstructured":"Tabrizi, S.J., Ghosh, R., and Leavitt, B.R. (2019). Huntingtin lowering strategies for disease modification in Huntington\u2019s disease. Neuron, 101, 801\u2013819.","journal-title":"Neuron"},{"key":"1952_CR110","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1093\/molbev\/mst119","volume":"30","author":"E Tarazona-Santos","year":"2013","unstructured":"Tarazona-Santos, E., Machado, M., Magalh\u00e3es, W.C.S., Chen, R., Lyon, F., Burdett, L., Crenshaw, A., Fabbri, C., Pereira, L., Pinto, L., et al. (2013). Evolutionary dynamics of the human NADPH oxidase genes CYBB, CYBA, NCF2, and NCF4: functional implications. Mol Biol Evol, 30, 2157\u20132167.","journal-title":"Mol Biol Evol"},{"key":"1952_CR111","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1056\/NEJMoa1705342","volume":"378","author":"AA Thompson","year":"2018","unstructured":"Thompson, A.A., Walters, M.C., Kwiatkowski, J., Rasko, J.E.J., Ribeil, J. A., Hongeng, S., Magrin, E., Schiller, G.J., Payen, E., Semeraro, M., et al. (2018). Gene therapy in patients with transfusion-dependent \u03b2- thalassemia. N Engl J Med, 378, 1479\u20131493.","journal-title":"N Engl J Med"},{"key":"1952_CR112","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1089\/hum.2019.220","volume":"31","author":"P Tornabene","year":"2020","unstructured":"Tornabene, P., and Trapani, I. (2020). Can adeno-associated viral vectors deliver effectively large genes? Hum Gene Ther, 31, 47\u201356.","journal-title":"Hum Gene Ther"},{"key":"1952_CR113","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1089\/hum.2018.061","volume":"29","author":"F Urbinati","year":"2018","unstructured":"Urbinati, F., Campo Fernandez, B., Masiuk, K.E., Poletti, V., Hollis, R.P., Koziol, C., Kaufman, M.L., Brown, D., Mavilio, F., and Kohn, D.B. (2018). Gene therapy for sickle cell disease: A lentiviral vector comparison study. Hum Gene Ther, 29, 1153\u20131166.","journal-title":"Hum Gene Ther"},{"key":"1952_CR114","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/978-1-4939-7825-0_21","volume-title":"Huntington\u2019s Disease. Methods in Molecular Biology","author":"G Vachey","year":"2018","unstructured":"Vachey, G., and D\u00e9glon, N. (2018). CRISPR\/Cas9-mediated genome editing for Huntington\u2019s disease. In: Precious, S., Rosser, A., and Dunnett, S., eds. Huntington\u2019s Disease. Methods in Molecular Biology. New York: Humana Press. 463\u2013481."},{"key":"1952_CR115","doi-asserted-by":"publisher","first-page":"e0182896.","DOI":"10.1371\/journal.pone.0182896","volume":"12","author":"JM Van Kampen","year":"2017","unstructured":"Van Kampen, J.M., and Kay, D.G. (2017). Progranulin gene delivery reduces plaque burden and synaptic atrophy in a mouse model of Alzheimer\u2019s disease. PLoS ONE, 12, e0182896.","journal-title":"PLoS ONE"},{"key":"1952_CR116","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1089\/104303400750038507","volume":"11","author":"R Wagner","year":"2000","unstructured":"Wagner, R., Graf, M., Bieler, K., Wolf, H., Grunwald, T., Foley, P., and Uberla, K. (2000). Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors. Hum Gene Ther, 11, 2403\u20132413.","journal-title":"Hum Gene Ther"},{"key":"1952_CR117","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1073\/pnas.1524575113","volume":"113","author":"G Wang","year":"2016","unstructured":"Wang, G., Liu, X., Gaertig, M.A., Li, S., and Li, X.J. (2016a). Ablation of huntingtin in adult neurons is nondeleterious but its depletion in young mice causes acute pancreatitis. Proc Natl Acad Sci USA, 113, 3359\u20133364.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1952_CR118","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1007\/s11427-020-1756-9","volume":"63","author":"R Wang","year":"2020","unstructured":"Wang, R., Sun, H., Ren, H., and Wang, G. (2020). \u03b1-Synuclein aggregation and transmission in Parkinson\u2019s disease: a link to mitochondria and lysosome. Sci China Life Sci, 63, 1850\u20131859.","journal-title":"Sci China Life Sci"},{"key":"1952_CR119","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11427-016-5026-5","volume":"59","author":"W Wang","year":"2016","unstructured":"Wang, W., Qin, D.Y., Zhang, B.L., Wei, W., Wang, Y.S., and Wei, Y.Q. (2016b). Establishing guidelines for CAR-T cells: challenges and considerations. Sci China Life Sci, 59, 333\u2013339.","journal-title":"Sci China Life Sci"},{"key":"1952_CR120","doi-asserted-by":"publisher","first-page":"9654","DOI":"10.1073\/pnas.96.17.9654","volume":"96","author":"DA Wilcox","year":"1999","unstructured":"Wilcox, D.A., Olsen, J.C., Ishizawa, L., Griffith, M., and White Gilbert C., I.I. (1999). Integrin alpha IIb promoter-targeted expression of gene products in megakaryocytes derived from retrovirus-transduced human hematopoietic cells. Proc Natl Acad Sci USA, 96, 9654\u20139659.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1952_CR121","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1146\/annurev-genom-083117-021320","volume":"19","author":"TN Williams","year":"2018","unstructured":"Williams, T.N., and Thein, S.L. (2018). Sickle cell anemia and its phenotypes. Annu Rev Genomics Hum Genet, 19, 113\u2013147.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"1952_CR122","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41591-019-0421-7","volume":"25","author":"Z Ying","year":"2019","unstructured":"Ying, Z., Huang, X.F., Xiang, X., Liu, Y., Kang, X., Song, Y., Guo, X., Liu, H., Ding, N., Zhang, T., et al. (2019). A safe and potent anti-CD19 CAR T cell therapy. Nat Med, 25, 947\u2013953.","journal-title":"Nat Med"},{"key":"1952_CR123","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neurobiolaging.2019.02.003","volume":"78","author":"CY Zeng","year":"2019","unstructured":"Zeng, C.Y., Yang, T.T., Zhou, H.J., Zhao, Y., Kuang, X., Duan, W., and Du, J.R. (2019). Lentiviral vector-mediated overexpression of Klotho in the brain improves Alzheimer\u2019s disease-like pathology and cognitive deficits in mice. Neurobiol Aging, 78, 18\u201328.","journal-title":"Neurobiol Aging"},{"key":"1952_CR124","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s11064-016-1892-2","volume":"41","author":"JY Zhang","year":"2016","unstructured":"Zhang, J.Y., Deng, Y.N., Zhang, M., Su, H., and Qu, Q.M. (2016). SIRT3 acts as a neuroprotective agent in rotenone-induced parkinson cell model. Neurochem Res, 41, 1761\u20131773.","journal-title":"Neurochem Res"},{"key":"1952_CR125","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s11427-019-9665-8","volume":"63","author":"Z Zhao","year":"2020","unstructured":"Zhao, Z., Xiao, X., Saw, P.E., Wu, W., Huang, H., Chen, J., and Nie, Y. (2020). Chimeric antigen receptor T cells in solid tumors: a war against the tumor microenvironment. Sci China Life Sci 63, 180\u2013205.","journal-title":"Sci China Life Sci"},{"key":"1952_CR126","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1128\/JVI.73.4.2886-2892.1999","volume":"73","author":"R Zufferey","year":"1999","unstructured":"Zufferey, R., Donello, J.E., Trono, D., and Hope, T.J. (1999). Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 73, 2886\u20132892.","journal-title":"J Virol"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-021-1952-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11427-021-1952-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-021-1952-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T17:20:00Z","timestamp":1635355200000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11427-021-1952-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,14]]},"references-count":126,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["1952"],"URL":"https:\/\/doi.org\/10.1007\/s11427-021-1952-5","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,14]]},"assertion":[{"value":"30 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}